These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19077835)

  • 1. Assessing ribavirin exposure during pregnancy: the Ribavirin Pregnancy Registry.
    Roberts SS
    Gastroenterol Nurs; 2008; 31(6):413-7. PubMed ID: 19077835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
    Roberts SS; Miller RK; Jones JK; Lindsay KL; Greene MF; Maddrey WC; Williams IT; Liu J; Spiegel RJ
    Birth Defects Res A Clin Mol Teratol; 2010 Jul; 88(7):551-9. PubMed ID: 20564430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ribavirin].
    Taéron C
    Rev Infirm; 2009; (152):47-9. PubMed ID: 19702029
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacist's guide to pregnancy registry studies.
    Weiss SR; Cooke CE; Bradley LR; Manson JM
    J Am Pharm Assoc (Wash); 1999; 39(6):830-4. PubMed ID: 10609449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin for ribavirin-induced anemia in hepatitis C: more answers but many more questions.
    Dev A; Patel K; Muir A; McHutchison JG
    Am J Gastroenterol; 2003 Nov; 98(11):2344-7. PubMed ID: 14638332
    [No Abstract]   [Full Text] [Related]  

  • 6. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy.
    Brent RL
    Am J Obstet Gynecol; 2009 Jan; 200(1):4-24. PubMed ID: 19121655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data.
    Raebel MA; Ellis JL; Andrade SE
    Pharmacoepidemiol Drug Saf; 2005 Dec; 14(12):829-36. PubMed ID: 15800957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counseling pregnant women who may deliver extremely premature infants: medical care guidelines, family choices, and neonatal outcomes.
    Kaempf JW; Tomlinson MW; Campbell B; Ferguson L; Stewart VT
    Pediatrics; 2009 Jun; 123(6):1509-15. PubMed ID: 19482761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience.
    Tanioka D; Iwasaki Y; Araki Y; Osawa T; Ikeda H; Ando M; Kobashi H; Sakaguchi K; Shiratori Y; Yamamoto K
    Liver Int; 2009 May; 29(5):721-9. PubMed ID: 19141025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment.
    Sinclair SM; Jones JK; Miller RK; Greene MF; Kwo PY; Maddrey WC
    Drug Saf; 2017 Dec; 40(12):1205-1218. PubMed ID: 28689333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of herbs by pregnant and childbearing women: a risk-benefit assessment.
    Tiran D
    Complement Ther Nurs Midwifery; 2003 Nov; 9(4):176-81. PubMed ID: 14556766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S.M.A.R.T. mothers are resisting tobacco: prenatal smoking cessation in WIC mothers.
    Edwards MJ; Geiser T; Chafin C; Weatherby NL; Smith CM
    J Allied Health; 2009; 38(3):170-6. PubMed ID: 19753429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal education: priorities for perinatal nurses.
    Hanson L
    J Perinat Neonatal Nurs; 2008; 22(4):254-6. PubMed ID: 19011486
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of botanicals during pregnancy and lactation.
    Low Dog T
    Altern Ther Health Med; 2009; 15(1):54-8. PubMed ID: 19161049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final results from the ribavirin pregnancy registry, 2004-2020.
    Sinclair SM; Jones JK; Miller RK; Greene MF; Kwo PY; Maddrey WC
    Birth Defects Res; 2022 Dec; 114(20):1376-1391. PubMed ID: 36305304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
    Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
    Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin priming in patients with chronic hepatitis C and normal ALT: a pilot study.
    Töx U; Schulte S; Heindl B; Goeser T; Drebber U; Stelzer A; Steffen HM
    Hepatogastroenterology; 2008; 55(86-87):1666-70. PubMed ID: 19102366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity as a complication of pregnancy and labor.
    Kriebs JM
    J Perinat Neonatal Nurs; 2009; 23(1):15-22. PubMed ID: 19209055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living with hepatitis C and treatment: the personal experiences of patients.
    Sgorbini M; O'Brien L; Jackson D
    J Clin Nurs; 2009 Aug; 18(16):2282-91. PubMed ID: 19583661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.